Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in lab studies, though long-term safety in humans remains unknown.

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune | Cancer ...

Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta ...

"Prevention and early detection remain some of the most powerful tools we have to reduce cancer risk in the future." ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

The late Steve Jobs’s son set up a VC firm that backs startups and researchers working on cancer treatments. Now his Yosemite ...

“I love you so much, you’re the best man I’ve ever met,” Abbi Kerwin told her dad during the emotional ceremony ...

Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked pancreatic cancer in mouse models, shifting scientific attention away from insulin ...

The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP) ...

Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature ...